Home » GSK Settles Avandia Heart Attack Case on Trial’s Eve
GSK Settles Avandia Heart Attack Case on Trial’s Eve
GlaxoSmithKline Plc (GSK) said it settled on the eve of trial a lawsuit alleging its Avandia diabetes drug caused a North Carolina man to die of a heart attack, avoiding a jury determination over risks associated with the medicine.
San Francisco Chronicle
San Francisco Chronicle
Upcoming Events
-
07May
-
14May
-
30May